Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Ullem Scott B.. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Ullem Scott B. har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:ILMN / Illumina, Inc. | Director | 8 137 |
US:EW / Edwards Lifesciences Corporation | CVP, Chief Financial Officer | 39 898 |
US:BERY / Berry Global Group, Inc. | Director | 4 728 |
US:BMS / Bemis Co., Inc. | Vice President and CFO | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Ullem Scott B.. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Ullem Scott B. som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-07-02 |
|
4 | ILMN |
ILLUMINA, INC.
Common Stock |
A - Award | 307 | 8 137 | 3,92 | 81,20 | 24 928 | 660 723 | |
2025-05-23 |
|
4 | ILMN |
ILLUMINA, INC.
Common Stock |
A - Award | 3 780 | 7 830 | 93,33 | ||||
2025-05-20 |
|
4 | ILMN |
ILLUMINA, INC.
Common Stock |
F - Taxes | −1 070 | 4 050 | −20,90 | 83,62 | −89 473 | 338 661 | |
2025-05-12 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −1 200 | 39 898 | −2,92 | 73,68 | −88 416 | 2 939 685 | |
2025-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −11 250 | 41 098 | −21,49 | 74,40 | −837 035 | 3 057 819 |
2025-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 11 250 | 52 348 | 27,37 | 45,28 | 509 363 | 2 370 145 |
2025-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 13 400 | 41 098 | 48,38 | ||||
2025-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −1 406 | 27 698 | −4,83 | 74,92 | −105 338 | 2 075 134 | |
2025-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −648 | 29 104 | −2,18 | 75,65 | −49 021 | 2 201 718 | |
2025-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −635 | 29 752 | −2,09 | 75,65 | −48 038 | 2 250 739 | |
2025-04-01 |
|
4 | ILMN |
ILLUMINA, INC.
Common Stock |
A - Award | 229 | 5 120 | 4,68 | 104,92 | 24 027 | 537 200 | |
2025-03-26 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −11 250 | 30 387 | −27,02 | 70,87 | −797 267 | 2 153 472 |
2025-03-26 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 11 250 | 41 637 | 37,02 | 45,28 | 509 363 | 1 885 186 |
2025-02-28 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 760 | 30 387 | −20,34 | 70,52 | −547 204 | 2 142 770 |
2025-02-28 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −3 490 | 38 147 | −8,38 | 71,38 | −249 123 | 2 723 005 |
2025-02-28 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 11 250 | 41 637 | 37,02 | 45,28 | 509 363 | 1 885 186 |
2025-02-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −174 | 30 387 | −0,57 | 76,19 | −13 257 | 2 315 186 | |
2025-02-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −11 250 | 30 561 | −26,91 | 75,76 | −852 272 | 2 315 225 |
2025-02-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 11 250 | 41 811 | 36,81 | 45,28 | 509 363 | 1 893 064 |
2025-01-02 |
|
4 | ILMN |
ILLUMINA, INC.
Common Stock |
A - Award | 158 | 4 891 | 3,34 | 142,06 | 22 446 | 694 835 | |
2024-12-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −11 250 | 30 561 | −26,91 | 71,68 | −806 406 | 2 190 628 |
2024-12-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 11 250 | 41 811 | 36,81 | 45,28 | 509 363 | 1 893 064 |
2024-10-01 |
|
4 | ILMN |
ILLUMINA, INC.
Common Stock |
A - Award | 183 | 4 733 | 4,02 | 122,78 | 22 469 | 581 114 | |
2024-07-01 |
|
4 | ILMN |
ILLUMINA, INC.
Common Stock |
A - Award | 205 | 4 550 | 4,72 | 109,65 | 22 479 | 498 925 | |
2024-06-20 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −5 225 | 30 561 | −14,60 | 87,47 | −457 013 | 2 673 067 |
2024-06-20 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −400 | 35 786 | −1,11 | 88,11 | −35 245 | 3 153 194 |
2024-06-20 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 5 625 | 36 186 | 18,41 | 45,28 | 254 681 | 1 638 383 |
2024-05-21 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −5 625 | 30 561 | −15,54 | 90,45 | −508 803 | 2 764 362 |
2024-05-21 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 5 625 | 36 186 | 18,41 | 45,28 | 254 681 | 1 638 383 |
2024-05-17 |
|
4 | ILMN |
ILLUMINA, INC.
Common Stock |
A - Award | 2 622 | 4 292 | 157,01 | ||||
2024-05-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −1 198 | 30 561 | −3,77 | 86,72 | −103 891 | 2 650 250 | |
2024-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −790 | 31 759 | −2,43 | 85,09 | −67 221 | 2 702 373 | |
2024-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 11 075 | 32 549 | 51,57 | ||||
2024-05-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −4 431 | 21 474 | −17,10 | 85,25 | −377 743 | 1 830 658 | |
2024-05-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 7 465 | 25 905 | 40,48 | ||||
2024-05-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −634 | 18 440 | −3,32 | 85,06 | −53 928 | 1 568 506 | |
2024-04-30 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 550 | 19 074 | −25,56 | 85,74 | −561 579 | 1 635 353 |
2024-04-30 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −700 | 25 624 | −2,66 | 86,40 | −60 483 | 2 214 006 |
2024-04-30 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 250 | 26 324 | 38,01 | 36,75 | 266 438 | 967 407 |
2024-04-02 |
|
4 | ILMN |
ILLUMINA, INC.
Common Stock |
A - Award | 163 | 1 670 | 10,82 | 137,68 | 22 442 | 229 929 | |
2024-04-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 387 | 19 074 | −25,09 | 94,81 | −605 521 | 1 808 314 |
2024-04-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −868 | 25 461 | −3,30 | 95,51 | −82 903 | 2 431 780 |
2024-04-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 255 | 26 329 | 38,04 | 36,75 | 266 621 | 967 591 |
2024-02-29 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 255 | 19 074 | −27,56 | 85,59 | −620 923 | 1 632 458 |
2024-02-29 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 255 | 26 329 | 38,04 | 36,75 | 266 621 | 967 591 |
2024-02-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −174 | 19 074 | −0,90 | 86,04 | −14 971 | 1 641 127 | |
2024-02-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 255 | 19 248 | −27,37 | 78,29 | −567 994 | 1 506 926 |
2024-02-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 255 | 26 503 | 37,69 | 36,75 | 266 621 | 973 985 |
2023-12-29 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −14 510 | 19 248 | −42,98 | 76,55 | −1 110 794 | 1 473 506 |
2023-12-29 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 14 510 | 33 758 | 75,38 | 36,75 | 533 242 | 1 240 606 |
2023-11-28 |
|
4 | BERY |
BERRY GLOBAL GROUP, INC.
Common Stock |
M - Exercise | 1 970 | 4 728 | 71,43 | ||||
2023-10-31 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 255 | 19 248 | −27,37 | 62,66 | −454 569 | 1 206 001 |
2023-10-31 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 255 | 26 503 | 37,69 | 36,75 | 266 621 | 973 985 |
2023-09-29 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 255 | 19 248 | −27,37 | 69,54 | −504 527 | 1 338 544 |
2023-09-29 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 255 | 26 503 | 37,69 | 36,75 | 266 621 | 973 985 |
2023-08-31 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 255 | 19 248 | −27,37 | 77,79 | −564 366 | 1 497 302 |
2023-08-31 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 255 | 26 503 | 37,69 | 36,75 | 266 621 | 973 985 |
2023-07-31 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 255 | 19 248 | −27,37 | 84,35 | −611 959 | 1 623 569 |
2023-07-31 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 255 | 26 503 | 37,69 | 36,75 | 266 621 | 973 985 |
2023-06-30 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 255 | 19 248 | −27,37 | 93,27 | −676 674 | 1 795 261 |
2023-06-30 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 255 | 26 503 | 37,69 | 36,75 | 266 621 | 973 985 |
2023-06-06 | 3 | ILMN |
ILLUMINA, INC.
Common Stock |
0 | ||||||||
2023-06-06 |
|
4 | ILMN |
ILLUMINA, INC.
Common Stock |
A - Award | 1 507 | 1 507 | |||||
2023-05-17 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
G - Gift | 8 496 | 266 318 | 3,30 | ||||
2023-05-17 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
G - Gift | −8 496 | 19 248 | −30,62 | ||||
2023-05-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 9 450 | 27 744 | 51,66 | ||||
2023-05-11 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −64 119 | 18 294 | −77,80 | 88,36 | −5 665 619 | 1 616 476 |
2023-05-11 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −16 581 | 82 413 | −16,75 | 89,22 | −1 479 385 | 7 353 028 |
2023-05-11 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 80 700 | 98 994 | 441,13 | 35,20 | 2 840 374 | 3 484 262 |
2023-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −1 674 | 18 294 | −8,38 | 88,74 | −148 551 | 1 623 410 | |
2023-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −3 004 | 19 968 | −13,08 | 88,74 | −266 575 | 1 771 960 | |
2023-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 6 062 | 22 972 | 35,85 | ||||
2023-05-04 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −441 | 16 910 | −2,54 | 88,10 | −38 852 | 1 489 771 | |
2023-05-04 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −433 | 17 351 | −2,43 | 87,81 | −38 022 | 1 523 591 | |
2023-02-21 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −335 | 17 784 | −1,85 | 78,51 | −26 301 | 1 396 222 | |
2023-02-17 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 1 941 | 18 119 | 12,00 | ||||
2023-02-13 |
|
5 | EW |
Edwards Lifesciences Corp
Common Stock |
G - Gift | 13 083 | 257 822 | 5,35 | ||||
2023-02-13 |
|
5 | EW |
Edwards Lifesciences Corp
Common Stock |
G - Gift | −13 083 | 16 178 | −44,71 | ||||
2022-11-29 |
|
4 | BERY |
BERRY GLOBAL GROUP, INC.
Common Stock |
M - Exercise | 1 091 | 2 758 | 65,45 | ||||
2022-11-29 |
|
4 | BERY |
BERRY GLOBAL GROUP, INC.
Common Stock |
M - Exercise | 1 667 | 1 667 | |||||
2022-05-17 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −1 953 | 29 261 | −6,26 | 95,93 | −187 351 | 2 807 008 | |
2022-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
M - Exercise | −14 831 | 0 | −100,00 | ||||
2022-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −8 728 | 31 214 | −21,85 | 100,52 | −877 339 | 3 137 631 | |
2022-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 14 831 | 39 942 | 59,06 | ||||
2022-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −772 | 25 111 | −2,98 | 100,52 | −77 601 | 2 524 158 | |
2022-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −441 | 25 883 | −1,68 | 105,93 | −46 715 | 2 741 786 | |
2022-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 6 250 | 6 250 | |||||
2022-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 40 600 | 40 600 | |||||
2022-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 5 000 | 26 324 | 23,45 | ||||
2022-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
G - Gift | 15 488 | 244 739 | 6,76 | ||||
2022-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
G - Gift | −15 488 | 21 324 | −42,07 | ||||
2022-02-22 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −319 | 36 812 | −0,86 | 105,62 | −33 693 | 3 888 083 | |
2021-11-30 |
|
4 | BERY |
BERRY GLOBAL GROUP, INC.
Director Stock Option (Right to Buy) |
A - Award | 3 497 | 50 997 | 7,36 | ||||
2021-11-30 |
|
4 | BERY |
BERRY GLOBAL GROUP, INC.
Restricted Stock Units |
A - Award | 1 091 | 2 758 | 65,45 | ||||
2021-05-19 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
M - Exercise | −17 193 | 0 | −100,00 | ||||
2021-05-19 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −8 525 | 37 131 | −18,67 | 89,49 | −762 902 | 3 322 853 | |
2021-05-19 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −1 643 | 45 656 | −3,47 | 89,49 | −147 032 | 4 085 755 | |
2021-05-19 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 17 193 | 47 299 | 57,11 | ||||
2021-05-12 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −1 570 | 30 106 | −4,96 | 90,40 | −141 928 | 2 721 582 | |
2021-05-11 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −538 | 31 676 | −1,67 | 91,75 | −49 362 | 2 906 273 | |
2021-05-06 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 6 375 | 6 375 | |||||
2021-05-06 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 44 400 | 44 400 | |||||
2021-05-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 5 100 | 32 214 | 18,81 | ||||
2020-11-24 |
|
4 | BERY |
BERRY GLOBAL GROUP, INC.
Director Stock Option (Right to Buy) |
A - Award | 5 000 | 47 500 | 11,76 | ||||
2020-11-24 |
|
4 | BERY |
BERRY GLOBAL GROUP, INC.
Restricted Stock Units |
A - Award | 1 667 | 1 667 | |||||
2020-10-26 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −33 150 | 0 | −100,00 | |||
2020-10-26 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −19 229 | 27 114 | −41,49 | 79,20 | −1 522 989 | 2 147 502 |
2020-10-26 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −13 921 | 46 343 | −23,10 | 78,26 | −1 089 400 | 3 626 613 |
2020-10-26 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 33 150 | 60 264 | 122,26 | 21,76 | 721 344 | 1 311 345 |
2020-10-13 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −33 150 | 33 150 | −50,00 | |||
2020-10-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −27 500 | 27 114 | −50,35 | 83,69 | −2 301 544 | 2 269 238 |
2020-10-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −5 650 | 54 614 | −9,38 | 84,37 | −476 673 | 4 607 614 |
2020-10-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 33 150 | 60 264 | 122,26 | 21,76 | 721 344 | 1 311 345 |
2020-09-28 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −33 150 | 66 300 | −33,33 | |||
2020-09-28 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −33 150 | 27 114 | −55,01 | 78,11 | −2 589 204 | 2 117 758 |
2020-09-28 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 33 150 | 60 264 | 122,26 | 21,76 | 721 344 | 1 311 345 |
2020-09-15 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −33 150 | 99 450 | −25,00 | |||
2020-09-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −33 150 | 27 114 | −55,01 | 83,43 | −2 765 748 | 2 262 156 |
2020-09-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 33 150 | 60 264 | 122,26 | 21,76 | 721 344 | 1 311 345 |
2020-09-14 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −26 700 | 0 | −100,00 | |||
2020-09-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −26 700 | 27 114 | −49,62 | 82,21 | −2 194 908 | 2 228 942 |
2020-09-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 26 700 | 53 814 | 98,47 | 13,98 | 373 266 | 752 320 |
2020-08-06 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −26 700 | 26 700 | −50,00 | |||
2020-08-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −26 700 | 27 114 | −49,62 | 77,31 | −2 064 089 | 2 096 094 |
2020-08-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 26 700 | 53 814 | 98,47 | 13,98 | 373 266 | 752 320 |
2020-07-06 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −26 700 | 53 400 | −33,33 | |||
2020-07-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −26 700 | 27 114 | −49,62 | 69,98 | −1 868 389 | 1 897 359 |
2020-07-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 26 700 | 53 814 | 98,47 | 13,98 | 373 266 | 752 320 |
2020-06-22 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −26 700 | 80 100 | −25,00 | |||
2020-06-22 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −24 479 | 27 114 | −47,45 | 69,45 | −1 700 037 | 1 883 035 |
2020-06-22 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 221 | 51 593 | −4,13 | 70,19 | −155 891 | 3 621 297 |
2020-06-22 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 26 700 | 53 814 | 98,47 | 13,98 | 373 266 | 752 320 |
2020-06-22 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
G - Gift | 14 487 | 229 251 | 6,75 | ||||
2020-06-22 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
G - Gift | −14 487 | 27 114 | −34,82 | ||||
2020-05-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −726 | 13 867 | −4,97 | 225,05 | −163 386 | 3 120 768 | |
2020-05-13 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
M - Exercise | −6 606 | 0 | −100,00 | ||||
2020-05-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −3 276 | 14 593 | −18,33 | 217,84 | −713 644 | 3 178 939 | |
2020-05-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −750 | 17 869 | −4,03 | 217,84 | −163 380 | 3 892 583 | |
2020-05-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 6 606 | 18 619 | 54,99 | ||||
2020-05-08 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 2 575 | 2 575 | |||||
2020-05-08 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 18 700 | 18 700 | |||||
2020-05-08 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 2 075 | 12 013 | 20,88 | ||||
2020-01-07 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −7 500 | 35 600 | −17,40 | |||
2020-01-07 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 500 | 9 938 | −43,01 | 234,25 | −1 756 875 | 2 327 976 |
2020-01-07 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 500 | 17 438 | 75,47 | 41,94 | 314 550 | 731 350 |
2019-12-10 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −7 500 | 43 100 | −14,82 | |||
2019-12-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 500 | 9 938 | −43,01 | 233,88 | −1 754 100 | 2 324 299 |
2019-12-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 500 | 17 438 | 75,47 | 41,94 | 314 550 | 731 350 |
2019-11-26 |
|
4 | BERY |
BERRY GLOBAL GROUP, INC.
Director Stock Option (Right to Buy) |
A - Award | 11 500 | 42 500 | 37,10 | ||||
2019-11-12 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −7 500 | 50 600 | −12,91 | |||
2019-11-12 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 500 | 9 938 | −43,01 | 234,28 | −1 757 100 | 2 328 275 |
2019-11-12 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 500 | 17 438 | 75,47 | 41,94 | 314 550 | 731 350 |
2019-10-30 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −7 500 | 58 100 | −11,43 | |||
2019-10-30 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 500 | 9 938 | −43,01 | 235,30 | −1 764 750 | 2 338 411 |
2019-10-30 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 500 | 17 438 | 75,47 | 41,94 | 314 550 | 731 350 |
2019-10-30 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
G - Gift | 3 626 | 71 588 | 5,34 | ||||
2019-10-30 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
G - Gift | −3 626 | 9 938 | −26,73 | ||||
2019-09-09 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −7 500 | 65 600 | −10,26 | |||
2019-09-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 500 | 13 564 | −35,61 | 225,74 | −1 693 050 | 3 061 937 |
2019-09-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 500 | 21 064 | 55,29 | 41,94 | 314 550 | 883 424 |
2019-08-26 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −7 500 | 73 100 | −9,31 | |||
2019-08-26 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 500 | 13 564 | −35,61 | 213,44 | −1 600 800 | 2 895 100 |
2019-08-26 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 7 500 | 21 064 | 55,29 | 41,94 | 314 550 | 883 424 |
2019-05-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −1 104 | 13 564 | −7,53 | 178,17 | −196 700 | 2 416 698 | |
2019-05-14 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
M - Exercise | −2 784 | 0 | −100,00 | ||||
2019-05-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −1 236 | 14 668 | −7,77 | 181,10 | −223 840 | 2 656 375 | |
2019-05-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −506 | 15 904 | −3,08 | 181,10 | −91 637 | 2 880 214 | |
2019-05-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 2 784 | 16 410 | 20,43 | ||||
2019-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 2 825 | 2 825 | |||||
2019-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 19 900 | 19 900 | |||||
2019-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 2 250 | 13 626 | 19,78 | ||||
2019-02-26 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 575 | 11 376 | 5,32 | ||||
2019-02-12 |
|
5 | EW |
Edwards Lifesciences Corp
Common Stock |
G - Gift | 5 182 | 67 962 | 8,25 | ||||
2019-02-12 |
|
5 | EW |
Edwards Lifesciences Corp
Common Stock |
G - Gift | −5 182 | 10 801 | −32,42 | ||||
2019-02-06 |
|
4 | BERY |
BERRY GLOBAL GROUP INC
Director Stock Option (Right To Buy) |
A - Award | 8 000 | 31 000 | 34,78 | ||||
2018-09-07 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −25 036 | 0 | −100,00 | |||
2018-09-07 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −20 936 | 15 983 | −56,71 | 139,81 | −2 927 098 | 2 234 610 |
2018-09-07 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 300 | 36 919 | −5,86 | 140,76 | −323 748 | 5 196 718 |
2018-09-07 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −1 800 | 39 219 | −4,39 | 141,81 | −255 262 | 5 561 733 |
2018-09-07 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 25 036 | 41 019 | 156,64 | 34,05 | 852 476 | 1 396 697 |
2018-08-17 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −25 000 | 25 036 | −49,96 | |||
2018-08-17 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −8 700 | 15 983 | −35,25 | 137,14 | −1 193 161 | 2 191 987 |
2018-08-17 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 522 | 24 683 | −23,36 | 135,10 | −1 016 189 | 3 334 565 |
2018-08-17 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −5 169 | 32 205 | −13,83 | 137,86 | −712 594 | 4 439 756 |
2018-08-17 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −3 609 | 37 374 | −8,81 | 136,10 | −491 168 | 5 086 429 |
2018-08-17 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 25 000 | 40 983 | 156,42 | 34,05 | 851 250 | 1 395 471 |
2018-07-12 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −282 | 15 983 | −1,73 | 146,99 | −41 451 | 2 349 341 | |
2018-07-06 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −25 000 | 50 036 | −33,32 | |||
2018-07-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −24 200 | 16 265 | −59,80 | 145,65 | −3 524 803 | 2 369 046 |
2018-07-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −800 | 40 465 | −1,94 | 146,29 | −117 034 | 5 919 746 |
2018-07-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 25 000 | 41 265 | 153,70 | 34,05 | 851 250 | 1 405 073 |
2018-06-06 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −25 000 | 75 036 | −24,99 | |||
2018-06-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −16 510 | 16 265 | −50,37 | 140,79 | −2 324 398 | 2 289 905 |
2018-06-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −8 490 | 32 775 | −20,57 | 141,62 | −1 202 362 | 4 641 628 |
2018-06-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 25 000 | 41 265 | 153,70 | 34,05 | 851 250 | 1 405 073 |
2018-05-21 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 3 275 | 3 275 | |||||
2018-05-21 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 22 500 | 22 500 | |||||
2018-05-21 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 2 625 | 16 265 | 19,24 | ||||
2018-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
M - Exercise | −9 712 | 0 | −100,00 | ||||
2018-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −4 816 | 13 640 | −26,09 | 136,43 | −657 047 | 1 860 905 | |
2018-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 9 712 | 18 456 | 111,07 | ||||
2018-05-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
G - Gift | 1 121 | 62 780 | 1,82 | ||||
2018-05-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
G - Gift | −1 121 | 8 744 | −11,36 | ||||
2018-05-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −1 103 | 9 865 | −10,06 | 138,11 | −152 335 | 1 362 455 | |
2018-05-11 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −25 000 | 100 036 | −19,99 | |||
2018-05-11 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −14 253 | 10 968 | −56,51 | 135,16 | −1 926 410 | 1 482 415 |
2018-05-11 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −8 847 | 25 221 | −25,97 | 133,86 | −1 184 220 | 3 375 972 |
2018-05-11 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −1 900 | 34 068 | −5,28 | 135,59 | −257 613 | 4 619 137 |
2018-05-11 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 25 000 | 35 968 | 227,94 | 34,05 | 851 250 | 1 224 710 |
2018-04-05 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −25 000 | 125 036 | −16,66 | |||
2018-04-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 544 | 10 968 | −37,37 | 138,47 | −906 132 | 1 518 713 |
2018-04-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −5 546 | 17 512 | −24,05 | 135,43 | −751 107 | 2 371 689 |
2018-04-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −5 300 | 23 058 | −18,69 | 137,30 | −727 707 | 3 165 937 |
2018-04-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −4 690 | 28 358 | −14,19 | 136,12 | −638 385 | 3 859 980 |
2018-04-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 920 | 33 048 | −8,12 | 139,00 | −405 869 | 4 593 543 |
2018-04-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 25 000 | 35 968 | 227,94 | 34,05 | 851 250 | 1 224 710 |
2018-03-30 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −25 000 | 150 036 | −14,28 | |||
2018-03-30 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −16 730 | 10 968 | −60,40 | 137,06 | −2 292 997 | 1 503 263 |
2018-03-30 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 170 | 27 698 | −20,56 | 137,73 | −987 507 | 3 814 779 |
2018-03-30 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −1 100 | 34 868 | −3,06 | 138,75 | −152 622 | 4 837 841 |
2018-03-30 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 25 000 | 35 968 | 227,94 | 34,05 | 851 250 | 1 224 710 |
2018-02-22 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
G - Gift | 14 055 | 61 659 | 29,52 | ||||
2018-02-22 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
G - Gift | −14 055 | 10 968 | −56,17 | ||||
2018-02-22 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −11 643 | 25 023 | −31,75 | 133,82 | −1 558 066 | 3 348 578 | |
2018-02-13 |
|
4 | BERY |
BERRY GLOBAL GROUP INC
Director Stock Option (Right To Buy) |
A - Award | 6 500 | 23 000 | 39,39 | ||||
2017-07-11 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −297 | 36 666 | −0,80 | 118,17 | −35 096 | 4 332 821 | |
2017-05-15 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 3 775 | 3 775 | |||||
2017-05-15 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 26 600 | 26 600 | |||||
2017-05-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 3 025 | 37 234 | 8,84 | ||||
2017-05-12 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
M - Exercise | −10 500 | 0 | −100,00 | ||||
2017-05-12 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −5 479 | 39 230 | −12,25 | 110,58 | −605 868 | 4 338 053 | |
2017-05-12 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 10 500 | 44 709 | 30,69 | ||||
2017-02-24 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −11 815 | 34 209 | −25,67 | 89,74 | −1 060 278 | 3 069 916 | |
2017-02-09 |
|
4 | BERY |
BERRY PLASTICS GROUP INC
Employee Stock Option (Right to Buy) |
A - Award | 7 500 | 16 500 | 83,33 | ||||
2016-09-08 |
|
4 | BERY |
BERRY PLASTICS GROUP INC
Director Stock Options (right to buy) |
A - Award | 9 000 | 9 000 | |||||
2016-08-08 | 3 | BERY |
BERRY PLASTICS GROUP INC
Common Stock |
0 | ||||||||
2016-05-16 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 3 675 | 3 675 | |||||
2016-05-16 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 26 900 | 26 900 | |||||
2016-05-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 2 925 | 88 336 | 3,42 | ||||
2016-02-23 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −11 745 | 85 411 | −12,09 | 86,21 | −1 012 536 | 7 363 282 | |
2015-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 2 775 | 2 775 | |||||
2015-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 22 100 | 22 100 | |||||
2015-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 2 225 | 48 578 | 4,80 | ||||
2015-02-23 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −5 611 | 46 353 | −10,80 | 133,72 | −750 303 | 6 198 323 | |
2014-07-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 568 | 51 964 | 1,11 | ||||
2014-05-12 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 3 000 | 3 000 | |||||
2014-05-12 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 40 300 | 40 300 | |||||
2014-02-24 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 87 518 | 87 518 | |||||
2014-02-24 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 51 396 | 51 396 | |||||
2013-10-08 |
|
4 | BMS |
BEMIS CO INC
Restricted Stock |
M - Exercise | −25 000 | 0 | −100,00 | ||||
2013-10-08 |
|
4 | BMS |
BEMIS CO INC
Common Stock |
F - Taxes | −11 480 | 22 594 | −33,69 | 38,24 | −438 995 | 863 995 | |
2013-10-08 |
|
4 | BMS |
BEMIS CO INC
Common Stock |
M - Exercise | 25 000 | 34 074 | 275,51 | ||||
2013-02-08 |
|
4 | BMS |
BEMIS CO INC
Performance Unit |
M - Exercise | −14 387 | 0 | −100,00 | ||||
2013-02-08 |
|
4 | BMS |
BEMIS CO INC
Common Stock |
F - Taxes | −2 760 | 9 074 | −23,32 | 36,50 | −100 740 | 331 201 | |
2013-02-08 |
|
4 | BMS |
BEMIS CO INC
Common Stock |
M - Exercise | 7 870 | 11 834 | 198,54 | ||||
2013-01-04 |
|
4 | BMS |
BEMIS CO INC
Performance Unit |
A - Award | 12 798 | 12 798 | |||||
2013-01-04 |
|
4 | BMS |
BEMIS CO INC
Restricted Stock Unit |
A - Award | 12 798 | 12 798 | |||||
2012-02-03 |
|
4 | BMS |
BEMIS CO INC
Performance Unit |
M - Exercise | −11 465 | 0 | −100,00 | ||||
2012-02-03 |
|
4 | BMS |
BEMIS CO INC
Common Stock |
F - Taxes | −2 056 | 3 964 | −34,15 | 31,52 | −64 805 | 124 945 | |
2012-02-03 |
|
4 | BMS |
BEMIS CO INC
Common Stock |
M - Exercise | 6 020 | 6 020 | |||||
2012-01-05 |
|
4 | BMS |
BEMIS CO INC
Performance Unit |
A - Award | 13 976 | 13 976 | |||||
2012-01-05 |
|
4 | BMS |
BEMIS CO INC
Restricted Stock Unit |
A - Award | 13 976 | 13 976 | |||||
2011-01-04 |
|
4 | BMS |
BEMIS CO INC
Restricted Stock Unit |
A - Award | 12 568 | 12 568 | |||||
2011-01-04 |
|
4 | BMS |
BEMIS CO INC
Performance Unit |
A - Award | 12 568 | 12 568 |